J Alan Erickson

Summary

Affiliation: ARUP Institute for Clinical and Experimental Pathology
Country: USA

Publications

  1. ncbi request reprint Quantitative spectrophotometric microplate assay for angiotensin-converting enzyme in cerebrospinal fluid
    J Alan Erickson
    ARUP Institute for Clinical and Experimental Pathology, LLC, Salt Lake City, UT 84108, USA
    Clin Chem 49:970-2. 2003
  2. ncbi request reprint Evaluation of a dimeric inhibin-A assay for assessing fetal Down syndrome: establishment, comparison, and monitoring of median concentrations for normal pregnancies
    J Alan Erickson
    ARUP Institute for Clinical and Experimental Pathology, LLC, Salt Lake City, Utah 84108, USA
    Arch Pathol Lab Med 128:415-20. 2004
  3. doi request reprint Evaluation of a fecal pancreatic elastase-1 enzyme-linked immunosorbent assay: Assessment versus an established assay and implication in classifying pancreatic function
    J Alan Erickson
    ARUP Laboratories, ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, Utah 84108, USA
    Clin Chim Acta 397:87-91. 2008
  4. doi request reprint Immunoassay for quantifying squamous cell carcinoma antigen in serum
    J Alan Erickson
    ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT 84108, USA
    Clin Chem 56:1496-9. 2010
  5. doi request reprint Comparison of three assays for quantifying S-100B in serum
    J Alan Erickson
    ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT 84108, USA
    Clin Chim Acta 412:2122-7. 2011
  6. doi request reprint Performance characteristics of the Access Inhibin A assay
    Mindy L Rawlins
    ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT 84108, USA
    Clin Chim Acta 397:32-5. 2008
  7. doi request reprint Performance characteristics of an automated assay for the quantitation of CYFRA 21-1 in human serum
    Jay L Patel
    Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112, USA
    Clin Biochem 43:1449-52. 2010
  8. doi request reprint A chromogranin A ELISA absent of an apparent high-dose hook effect observed in other chromogranin A ELISAs
    J Alan Erickson
    ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States
    Clin Chim Acta 452:120-3. 2016

Collaborators

Detail Information

Publications8

  1. ncbi request reprint Quantitative spectrophotometric microplate assay for angiotensin-converting enzyme in cerebrospinal fluid
    J Alan Erickson
    ARUP Institute for Clinical and Experimental Pathology, LLC, Salt Lake City, UT 84108, USA
    Clin Chem 49:970-2. 2003
  2. ncbi request reprint Evaluation of a dimeric inhibin-A assay for assessing fetal Down syndrome: establishment, comparison, and monitoring of median concentrations for normal pregnancies
    J Alan Erickson
    ARUP Institute for Clinical and Experimental Pathology, LLC, Salt Lake City, Utah 84108, USA
    Arch Pathol Lab Med 128:415-20. 2004
    ..The majority, however, use the Serotec inhibin-A assay and not the newer Diagnostic Systems Laboratories inhibin-A enzyme-linked immunosorbent assay (ELISA)...
  3. doi request reprint Evaluation of a fecal pancreatic elastase-1 enzyme-linked immunosorbent assay: Assessment versus an established assay and implication in classifying pancreatic function
    J Alan Erickson
    ARUP Laboratories, ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, Utah 84108, USA
    Clin Chim Acta 397:87-91. 2008
    ..Disagreement continues regarding 2 fecal pancreatic elastase-1 (PE-1) ELISAs and their respective capabilities to assess pancreatic function...
  4. doi request reprint Immunoassay for quantifying squamous cell carcinoma antigen in serum
    J Alan Erickson
    ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT 84108, USA
    Clin Chem 56:1496-9. 2010
    ..Because SCCa quantification still has demonstrated clinical utility, we developed and validated a microtiter plate-based ELISA for measuring SCCa in serum...
  5. doi request reprint Comparison of three assays for quantifying S-100B in serum
    J Alan Erickson
    ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT 84108, USA
    Clin Chim Acta 412:2122-7. 2011
    ..Serum S-100B has clinical value in monitoring malignant melanoma and in monitoring and predicting outcomes in patients with traumatic brain injury...
  6. doi request reprint Performance characteristics of the Access Inhibin A assay
    Mindy L Rawlins
    ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT 84108, USA
    Clin Chim Acta 397:32-5. 2008
    ..Inhibin A may also have utility as a serum tumor marker in postmenopausal women with ovarian cancer and men with testicular stromal tumors...
  7. doi request reprint Performance characteristics of an automated assay for the quantitation of CYFRA 21-1 in human serum
    Jay L Patel
    Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112, USA
    Clin Biochem 43:1449-52. 2010
    ..We describe analytical performance characteristics of a novel CYFRA 21-1 assay and hypothesize that CYFRA 21-1 complements the clinical sensitivity of carcinoembryonic antigen (CEA) and squamous cell carcinoma antigen (SCCa)...
  8. doi request reprint A chromogranin A ELISA absent of an apparent high-dose hook effect observed in other chromogranin A ELISAs
    J Alan Erickson
    ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, United States
    Clin Chim Acta 452:120-3. 2016
    ..Here we describe the analytical performance characteristics of the Chromoaâ„¢ CgA ELISA that did not display the apparent high-dose hook effect...